All posts tagged
Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug
Make your Biotech Career blossom with this Week’s best Job Offers!
Galapagos kicks off a Phase IIa trial for Cystic Fibrosis
World Cancer Day is Saturday! Europe’s Oncology in Numbers
Don’t let your Biotech Career freeze: Heat it up at Immunocore or Qiagen!
On the Job Hunt? Score a Biotech Career at Evotec or Merck!
One Step Closer to the First Triple Combination Therapy for Cystic Fibrosis
UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug
New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira
Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis
Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie
Labiotech UG, All Rights Reserved -
Send this to friend